Tevogen Bio Holdings Inc.TVGNNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
15.21%
↓ 87% below average
Average (17q)
114.24%
Historical baseline
Range
High:2191.90%
Low:-80.18%
Volatility
1988.9%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 15.21% |
| Q2 2025 | -15.50% |
| Q1 2025 | 12.65% |
| Q4 2024 | -13.02% |
| Q3 2024 | -20.94% |
| Q2 2024 | -80.18% |
| Q1 2024 | 2191.90% |
| Q4 2023 | -18.70% |
| Q3 2023 | 8.29% |
| Q2 2023 | -23.44% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |